Related references
Note: Only part of the references are listed.A novel nucleic acid analogue shows strong angiogenic activity
Ikuko Tsukamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Endothelial Dysfunction Associated with Hypercortisolism is Reversible in Cushing's Syndrome
Itaru Akaza et al.
ENDOCRINE JOURNAL (2010)
Corticosteroid Suppression of VEGF-A in Infantile Hemangioma-Derived Stem Cells.
Shoshana Greenberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Paired Hormone Response Elements Predict Caveolin-1 as a Glucocorticoid Target Gene
Marinus F. van Batenburg et al.
PLOS ONE (2010)
Transforming growth factor-β1 downregulates caveolin-1 expression and enhances sphingosine 1-phosphate signaling in cultured vascular endothelial cells
Junsuke Igarashi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Caveolae as organizers of pharmacologically relevant signal transduction molecules
Hemal H. Patel et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Cardiovascular outcomes in patients with primary aldosteronism after treatment
Cristiana Catena et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome
C. Kristo et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
Angiogenesis: A potentially critical part of remodelling in chronic airway diseases?
Eugene Haydn Walters et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Vascular cell signaling by membrane estrogen receptors
Kyuny Hee Kim et al.
STEROIDS (2008)
Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins
J. Igarashi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cell selective glucocorticoid induction of caveolin-1 and caveolae in differentiating pulmonary alveolar epithelial cell cultures
Jaleh Barar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells -: Evidence for an AMPK→Rac1→Akt→Endothelial nitric-oxide synthase pathway
Yehoshua C. Levine et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing's Syndrome
Merih Baykan et al.
ENDOCRINE (2007)
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity
Jane A. Leopold et al.
NATURE MEDICINE (2007)
Dexamethasone treatment and ICAM-1 deficiency impair VEGF-induced angiogenesis in adult brain
Lora J. Kasselman et al.
JOURNAL OF VASCULAR RESEARCH (2007)
Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation
M. Salatino et al.
ONCOGENE (2006)
Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity
Daisuke Nagata et al.
HYPERTENSION (2006)
Rac1 modulates sphingosine 1-phosphate-mediated activation of phosphoinositide 3-kinase/Akt signaling pathways in vascular endothelial cells
E Gonzalez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis
PM Bauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Dexamethasone delays ulcer healing by inhibition of angiogenesis in rat stomachs
JC Luo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Dexamethasone lacks effect on blood pressure in mice with a disrupted endothelial NO synthase gene
T Wallerath et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2004)
Role of caveolae and caveolins in health and disease
AW Cohen et al.
PHYSIOLOGICAL REVIEWS (2004)
Small interfering RNA-mediated down-regulation of caveolin-1 differentially modulates signaling pathways in endothelial cells
E Gonzalez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis
P Sonveaux et al.
CIRCULATION RESEARCH (2004)
High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines
T Mancini et al.
CLINICAL ENDOCRINOLOGY (2004)
Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol
L Labrecque et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk
L Tauchmanová et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Share Paper
